IMMUNOINTERVENTION IN PSORIASIS WITH ANTI–CD4 ANTIBODIES
- 31 May 1994
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 33 (5), 327-332
- https://doi.org/10.1111/j.1365-4362.1994.tb01062.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skinJournal of Dermatological Science, 1994
- Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibodyClinical Immunology and Immunopathology, 1992
- Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: In situ expression of β2-integrinsJournal of the American Academy of Dermatology, 1992
- Anti-CD4 monoclonal antibody therapy in severe psoriasisJournal of Autoimmunity, 1992
- Studies of the Effect of Cyclosporine in Psoriasis In Vivo: Combined Effects on Activated T Lymphocytes and Epidermal Regenerative MaturationJournal of Investigative Dermatology, 1992
- Peptide T improves psoriasis when infused into lesions in nanogram amountsJournal of the American Academy of Dermatology, 1991
- Interactions of epidermal cells and T cells in inflammatory skin diseasesJournal of the American Academy of Dermatology, 1990
- Cyclosporine A in the Treatment of Psoriasis: A Clinical and Mechanistic PerspectiveJournal of Investigative Dermatology, 1990
- Remission of psoriatic lesions with muromonab-CD3 (Orthoclone OKT3) treatmentJournal of the American Academy of Dermatology, 1989
- Clinical use of OKT3: The role of cytokine release and xenosensitizationJournal of Autoimmunity, 1988